Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00643526 · ClinicalTrials.gov registry record · Early Phase 1
A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector
A Early Phase 1 study, sponsored by Centocor.
- Completed
- Registry status
- Early Phase 1
- Development phase
- 68
- Enrollment target
NCT00643526: Completed Early Phase 1 study, sponsored by Centocor.
NCT00643526 is a Early Phase 1 study that has completed, run by Centocor. The registered enrollment target is 68 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (28% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00643526, a Early Phase 1 study, has completed, sponsored by Centocor.
- COMPLETED
- Registry status
- Early Phase 1
- Development phase
- 68 participants
- Enrollment target
Study Summary
The main purpose of this study is to evaluate how well the autoinjector works in a group of people who are likely to use the autoinjector for injecting their medicine in the future. However, no active medicine is given by the autoinjector.
Interventions
- DEVICE Pre-filled Auto-injector Containing Placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 68 participants |
| Start Date | 2007-12 |
| Est. Completion | 2008-01 |
| Phase | Early Phase 1 |
What the finished NCT00643526 record still lists
NCT00643526 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 68 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (28% higher).
The record links to 0 conditions, and to 1 intervention - of which Pre-filled Auto-injector Containing Placebo is the first listed.
NCT00643526 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00643526 about?
NCT00643526 is a clinical study titled "A Study to Test the Design, Functionality, and Ergonomic Features of the Autoinjector". The main purpose of this study is to evaluate how well the autoinjector works in a group of people who are likely to use the autoinjector for injecting their medicine in the future. However, no active medicine is given by the autoinjector.
What is the current status of trial NCT00643526?
This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 68 participants. The study started on 2007-12. Estimated completion is 2008-01.
What interventions are being tested in trial NCT00643526?
The interventions under investigation include: Pre-filled Auto-injector Containing Placebo (DEVICE).
Who is sponsoring clinical trial NCT00643526?
This trial is sponsored by Centocor, which has 33 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00643526's enrollment target sits among peer trials
68 357th of 2000 higher than 1,640 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02044497 · 68 participants · Phase 4
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
- NCT03779854 · 68 participants · Phase 2
Naive T Cell Depletion for Preventing Chronic Graft-versus-Host Disease in Children and Young Adults With Blood Cancers Undergoing Donor Stem Cell Transplant
- NCT03821246 · 68 participants · Phase 2
Neoadjuvant Atezolizumab-Based Combination Therapy in Men With Localized Prostate Cancer Prior to Radical Prostatectomy
- NCT04115514 · 68 participants · Phase 2
Treatment of ARDS With Instilled T3
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia